```json
{
  "treatment_information": [
    {
      "treatment_type": "endovascular embolization",
      "specific_treatment": "transarterial embolization of macro-arteriovenous fistula (MA VF)",
      "start_date": "Not specified",
      "end_date": "Not specified",
      "dosage_or_details": "3:1 mixture of N-butyl cyanoacrylate and ethiodol",
      "treatment_response": "Successful obliteration of the fistula; no neurological sequelae; reduction in size of the venous varix observed."
    }
  ],
  "treatment_timeline": [
    {
      "date": "2003-10-01",   // Approximation for understanding purposes; specific dates weren't mentioned.
      "event": "Screening CT scan revealed an asymptomatic arteriovenous malformation (AVM) of the spine."
    },
    {
      "date": "2004-06-01",  // Approximation for understanding purposes; this event would have happened after the screening.
      "event": "Spinal MR imaging revealed a perimedullary macro-AVF and a large venous varix within the spinal cord."
    },
    {
      "date": "2005-05-01",  // Approximation for understanding purposes; specific dates weren't mentioned.
      "event": "Transarterial embolization of the MA VF performed using N-butyl cyanoacrylate and ethiodol."
    },
    {
      "date": "2005-06-01",   // Approximation for understanding purposes; occurs shortly after embolization.
      "event": "Post-embolization imaging showed complete obliteration of the MA VF and no neurological dysfunction."
    },
    {
      "date": "2005-11-01",  // Approximation for understanding purposes; approximately 10 months post-embolization.
      "event": "Follow-up MR imaging showed complete resolution of T2 hyperintensity in the spinal cord."
    }
  ]
}
```